Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARKLE-L
NCT06794086Phase 3Recruiting
- Sponsor
- Jun Huang Lab
- Start
- Apr 2025
- Primary completion
- Jun 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of sintilimab in colorectal cancer (CRC), sponsored by Jun Huang Lab. Started Apr 2025; status: recruiting.
02
Drugs
sintilimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06794086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06794086.